TenSixteen Bio
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $30M
Investors
- 2
About TenSixteen Bio
Based in California, US, and founded in 2020, TenSixteen Bio, Inc. operates as a biotechnology company focused on developing novel therapeutics for a variety of diseases using somatic mosaicism and clonal hematopoiesis (CHIP) technique. The company was co-founded by CEO Mark Chao, physician-scientist and former co-founder of Forty Seven, an immuno-oncology company, and Pradeep Natarajan. In January 2022, TenSixteen Bio, Inc.1 million post-money. TenSixteen Bio is building a comprehensive multi-omics and clinical data platform on CHIP (clonal hematopoiesis of indeterminate potential) coupled with a proprietary diagnostic assay on CHIP, the platform will enable the company to discover therapeutic targets of CHIP, identify which patients are at the highest risk, and bring tailored therapies to these patients in the form of a biomarker.
Who invested in TenSixteen Bio
2 investors across 1 round
See all investors in TenSixteen Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 27, 2022
Amount
$30M
Investors
Questions about TenSixteen Bio
Who invested in TenSixteen Bio?
TenSixteen Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TenSixteen Bio raised?
TenSixteen Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TenSixteen Bio last raise money?
TenSixteen Bio's most recent round on record is a Series A, in Jan 2022.
What does TenSixteen Bio do?
Based in California, US, and founded in 2020, TenSixteen Bio, Inc.
Where is TenSixteen Bio headquartered?
TenSixteen Bio is headquartered in San Francisco, US.
Which VCs invest in companies like TenSixteen Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TenSixteen Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TenSixteen Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.